影响艾滋病毒感染者的治疗坚持因素 - - 土耳其单中心描述性研究
Sabri Atalay1, Kamil Mert2, Derya Caglayan3
1Department of Infectious Diseases and Clinical Microbiology, Izmir Tepecik Education and Research Hospital, University of HealthSciences, Izmir, Turkey.
HIV medicine
|May 6, 2025
概括
艾滋病毒感染者坚持治疗对于控制感染至关重要. 个人因素,如抑郁症和艾滋病毒/艾滋病相关问题显著影响坚持,需要量身定制的患者支持和咨询.
科学领域:
- 医学研究 医学研究
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
背景情况:
- 坚持治疗对于病毒抑制和艾滋病毒感染者的积极临床结果至关重要.
- 不良的坚持增加了治疗失败和疾病进展的风险.
- 了解坚持障碍是改善患者管理的关键.
研究的目的:
- 确定影响土耳其艾滋病毒感染者遵守治疗的因素.
- 为提高临床实践中的坚持策略提供见解.
主要方法:
- 在Tepecik培训和研究医院进行了基于问卷的研究.
- 参与者包括18岁以上的艾滋病毒感染者,至少六个月接受抗逆转录病毒疗法 (ART).
- 调查问卷评估了个人,与艾滋病毒/艾滋病相关的,与ART相关的和与医疗保健设施相关的因素.
主要成果:
- 抑郁症,治疗疲劳和担心有一个健康的孩子是突出的个人因素.
- 机会性感染/癌症的存在和缺乏治愈的信念是与艾滋病毒/艾滋病有关的主要障碍.
- 缺乏咨询和难以接触医生是医疗机构的主要障碍.
结论:
- 个人和与艾滋病毒/艾滋病相关的因素是治疗坚持的最重要障碍.
- 在诊断和随访期间提供量身定制的咨询对于改善遵守是必不可少的.
- 解决心理和疾病特异性的问题可以提高治疗结果.
相关概念视频
Drug Therapy
26
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
26
Pulmonary Tuberculosis I
198
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
198
Factors Affecting Protein-Drug Binding: Patient-Related Factors
31
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
31
Pulmonary Tuberculosis V
145
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
145
Factors Affecting Protein-Drug Binding: Drug-Related Factors
53
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
53
Factors Influencing Drug Absorption: Disease States and Pharmacology
338
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
338


